EUVIMEDEUVIMED entdecken
Fallbericht

Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience

Bibi Shahin Shamsian, Mohammad Reza Jafari, Hassan Abolghasemi, Peyman Eshghi, Mohammad Ali Ehsani, Elham Shahgholi, Maryam Kazemi Aghdam, Atbin Latifi, Mahnaz Jamee

Experimental and Clinical Transplantation · 2023

DOI: 10.6002/ect.2022.0081 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Experimental and Clinical Transplantation, 2023. Verfasst von Bibi Shahin Shamsian und 8 weiteren Autor:innen. Beteiligte Einrichtung: From the Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical …. Hauptthemen laut MEDLINE: Graft vs Host Disease, Anemia, Sideroblastic, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital sideroblastic anemia is characterized by anemia and intramitochondrial iron accumulation in erythroid precursors that form ring sideroblasts. The most common recessive forms are caused by sequence variations in the ALAS2 and SLC25A38 genes. In patients with transfusion-dependent and pyridoxine- resistant severe congenital sideroblastic anemia, hematopoietic stem celltransplantis the only curative option. Herein, we described successful implementations of allogeneic hematopoietic stem cell transplant in 4 Iranian children with congenital sideroblastic anemia. The patients had presented with clinical manifestations of anemia early in life, and the diagnoses of congenital sideroblastic anemia were established through blood tests and bone marrow aspiration. Congenital sideroblastic anemia was further confirmed by the identification of pathogenic variants in SLC25A38 in 2 patients. All 4 patients received allogeneic hematopoietic stem cell transplant with myeloablative conditioning regimen that included busulfan, cyclophosphamide, andrabbit antithymocyte globulin. A combination of cyclosporine A and methotrexate or mycophenolate mofetil was used for graft-versus-host disease prophylaxis. Bone marrow and peripheral blood from sibling or related donors with fully matched human leukocyte antigen profiles were applied. The outcomes of hematopoietic stem celltransplantin patients with congenital sideroblastic anemia were favorable. Three patients achieved full donor chimerism (>95%, 98%, and 100%), and the other patient showed mixed chimerism (75%). All patients remained transfusion independent. Hemato- poietic stem celltransplantis a curative treatmentthat can provide long-term survival for patients with congenital sideroblastic anemia, particularly when used in a timely manner. There remain ongoing challenges in various aspects of hematopoietic stem celltransplantin patients with congenital sideroblastic anemia, which remain to be elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseAnemia, SideroblasticHematopoietic Stem Cell TransplantationGenetic Diseases, X-Linked5-Aminolevulinate SynthetaseIranChildCyclosporineHumansTransplantation Conditioning

Substanzen

5-Aminolevulinate SynthetaseALAS2 protein, humanCyclosporine

Autor:innen und Institutionen

  • From the Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Children's Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Zitieren

APA

Shamsian, B. S., Jafari, M. R., Abolghasemi, H., Eshghi, P., Ehsani, M. A., Shahgholi, E., Kazemi Aghdam, M., Latifi, A., & Jamee, M. (2023). Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience. Experimental and Clinical Transplantation. https://doi.org/10.6002/ect.2022.0081

Vancouver

Shamsian BS, Jafari MR, Abolghasemi H, Eshghi P, Ehsani MA, Shahgholi E, et al. Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience. Experimental and Clinical Transplantation. 2023. doi:10.6002/ect.2022.0081

BibTeX
@article{Shamsian2023,
  author = {Shamsian, Bibi Shahin and Jafari, Mohammad Reza and Abolghasemi, Hassan and Eshghi, Peyman and Ehsani, Mohammad Ali and Shahgholi, Elham and Kazemi Aghdam, Maryam and Latifi, Atbin and Jamee, Mahnaz},
  title = {Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience},
  journal = {Experimental and Clinical Transplantation},
  year = {2023},
  doi = {10.6002/ect.2022.0081}
}
Kostenlos starten →